Core Insights - Corteva, Inc. reported revenue of $4.42 billion for the quarter ended March 2025, reflecting a decrease of 1.7% year-over-year and a surprise of -2.04% compared to the Zacks Consensus Estimate of $4.51 billion [1] - The company's EPS was $1.13, which is an increase from $0.89 in the same quarter last year, resulting in an EPS surprise of +29.89% against the consensus estimate of $0.87 [1] Revenue Breakdown - Crop Protection revenue was $1.71 billion, below the four-analyst average estimate of $1.77 billion, with a year-over-year decline of -1.8% [4] - Seed revenue reached $2.71 billion, also below the four-analyst average estimate of $2.77 billion, marking a year-over-year decrease of -1.6% [4] Operating EBITDA Performance - Operating EBITDA for Crop Protection was reported at $377 million, exceeding the three-analyst average estimate of $337.09 million [4] - Operating EBITDA for Seed was $842 million, surpassing the average estimate of $738.94 million based on three analysts [4] Stock Performance - Corteva, Inc. shares have returned +12.5% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Corteva, Inc. (CTVA) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.89 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 29.89%. A quarter ago, it was expected that this agriculture would post earnings of $0.34 per share when it actually produced earnings of $0.32, delivering a surprise of -5.88%. Over the last four quarters, the comp ...

A-1 Corteva, Inc. Consolidated Statements of Operations (Dollars in millions, except per share amounts) | | | | Three Months Ende March 31, | | | --- | --- | --- | --- | --- | | | | 2025 | | 202 | | Net sales | $ | 4,417 | $ | 4, | | Cost of goods sold | | 2,342 | | 2, | | Research and development expense | | 335 | | | | Selling, general and administrative expenses | | 751 | | | | Amortization of intangibles | | 162 | | | | Restructuring and asset related charges - net | | 22 | | | | Other income (expense) ...

Core Viewpoint - Corteva, Inc. reported a mixed performance in Q1 2025, with a slight decline in net sales but an increase in organic sales, driven by strong demand for its technology and cost discipline [5][6][7]. Financial Performance - Net sales for Q1 2025 were $4.42 billion, a decrease of 2% compared to Q1 2024, while organic sales increased by 3% [2][7]. - GAAP income from continuing operations was $667 million, with earnings per share (EPS) of $0.97 [2][7]. - Non-GAAP operating EBITDA was $1.19 billion, and operating EPS was $1.13 [2][7]. Segment Performance - Seed net sales were $2.71 billion, down from $2.75 billion in Q1 2024, impacted by a 4% unfavorable currency effect and a 1% decline in volume, partially offset by a 3% price increase [8][11]. - Crop Protection net sales were approximately $1.71 billion, a decrease from $1.74 billion in Q1 2024, driven by a 5% unfavorable currency impact and a 2% price decline, despite a 5% increase in volume [11][12]. Regional Performance - North America saw seed net sales increase by 6%, while EMEA experienced a 7% decline [4][7]. - Latin America faced a 14% decline in seed net sales, and Asia Pacific saw a 5% decrease [4][7]. Guidance and Outlook - The company reaffirmed its full-year 2025 guidance, expecting net sales between $17.2 billion and $17.6 billion, with operating EBITDA projected at $3.6 billion to $3.8 billion [6][17]. - Corteva anticipates double-digit earnings growth and continued margin expansion throughout 2025 [6][17]. Operational Highlights - The company emphasized its focus on cost discipline and operational excellence, which contributed to net cost reductions and margin expansion [5][6]. - Segment operating EBITDA for seeds was $842 million, up 13% from the previous year, while Crop Protection's operating EBITDA was $377 million, reflecting a 22% increase [10][13].

Core Viewpoint - Analysts forecast that Corteva, Inc. (CTVA) will report quarterly earnings of $0.87 per share, reflecting a year-over-year decline of 2.3%, with anticipated revenues of $4.51 billion, showing a slight increase of 0.4% compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate for the quarter has been revised upward by 1.4% over the past 30 days, indicating a collective reassessment by analysts [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Estimates - The consensus estimate for 'Revenue- Seed' is $2.77 billion, indicating a year-over-year change of +0.6% [5]. - 'Revenue- Crop Protection' is forecasted to reach $1.77 billion, reflecting a year-over-year increase of +1.6% [5]. - 'Revenue- Crop Protection- Other' is projected at $152.48 million, showing a decline of -18.5% from the previous year [5]. - 'Revenue- Seed- Other' is expected to be $129.31 million, with a year-over-year increase of +1.8% [6]. - 'Revenue- Crop Protection- Herbicides' is anticipated to reach $938.41 million, indicating a +5.9% change from the prior year [6]. - 'Revenue- Crop Protection- Insecticides' is estimated at $386.54 million, reflecting a +3.6% year-over-year change [6]. - 'Revenue- Crop Protection- Fungicides' is expected to be $286.60 million, indicating a -2.9% change year over year [7]. - 'Revenue- Seed- Soybean' is projected at $288.06 million, reflecting a -1.4% change from the previous year [7]. - 'Revenue- Seed- Corn' is estimated at $2.08 billion, showing a -0.2% change year over year [7]. - 'Revenue- Seed- Other oilseeds' is expected to be $258.09 million, indicating a +5.3% change from the prior year [8]. Operating Metrics - 'Operating EBITDA- Seed' is projected to reach $738.94 million, compared to $748 million in the same quarter last year [8]. - 'Operating EBITDA- Crop Protection' is expected to be $337.09 million, up from $310 million reported in the same quarter of the previous year [8]. Stock Performance - Shares of Corteva, Inc. have increased by +1.2% over the past month, contrasting with a -0.5% move of the Zacks S&P 500 composite [9].

Puna Bio received its initial funding in 2022, led by At One Ventures, a US venture firm with deep roots in Silicon Valley. The capital enabled the establishment of the company's first laboratory and growth of its core team. Argentina-based agricultural technology company specializing in biological solutions for regenerative agriculture to expand into new markets, fueled by new capital infusion BUENOS AIRES, Argentina, April 22, 2025 /PRNewswire/ -- Today Puna Bio announced that it had closed a new round of ...

Core Viewpoint - Corteva (NYSE: CTVA) has been upgraded from Buy to Strong Buy following its Q4 earnings and recent macro events related to tariffs and commodity markets, indicating a positive outlook for the stock despite no dramatic changes in core business fundamentals [1]. Company Analysis - The core business fundamentals of Corteva have remained stable, suggesting resilience in its operations amidst external market pressures [1]. - The analyst emphasizes a focus on long-only investment opportunities that provide safe and growing dividends, aiming for superior risk-adjusted returns [1]. Market Context - Recent macro events, particularly concerning tariffs and commodity markets, have influenced the decision to upgrade Corteva's stock rating, highlighting the importance of external economic factors on investment strategies [1].

Core Industry Insights - The Zacks Agriculture – Operations industry is benefiting from ongoing innovation and increasing consumer demand for health-focused products, particularly alternative proteins [1][2] - Advancements in food processing technologies, improved grain-handling methods, and expanded storage capacity are supporting industry momentum [2] - The U.S. Department of Agriculture projects agricultural exports of $170.5 billion for fiscal 2025, driven by stronger grain and feed exports [6] Company Highlights Mission Produce - Engaged in sourcing, farming, packaging, marketing, and distribution of avocados, mangoes, and blueberries, Mission Produce has optimized per-unit margins through effective integration of sales and sourcing operations [19][20] - The Zacks Consensus Estimate for Mission Produce's fiscal 2025 earnings has increased by 19% in the past 30 days, although sales and earnings are expected to decline by 6.6% and 32.4% respectively from the previous year [21] Corteva - Corteva is positioned for above-market growth through its innovative product pipeline and strong market demand for naturally derived products [22] - The Zacks Consensus Estimate for Corteva's 2025 earnings suggests growth of 1.7% and 15.2% respectively from the year-ago period [23] Dole - Dole is expected to benefit from improved logistical efficiencies and a healthier supply-demand balance, which has led to better pricing conditions in Europe [24] - The Zacks Consensus Estimate for Dole's 2025 earnings suggests a growth of 4.7% from the previous year [25] Adecoagro - Adecoagro operates in farming, dairy, sugar, ethanol, and energy production, benefiting from high asset flexibility in a volatile market [26] - The Zacks Consensus Estimate for Adecoagro's 2025 earnings suggests declines of 3.2% and 41.1% respectively from the previous year [27] Industry Challenges - The industry faces challenges such as fluctuating commodity prices, rising input costs, trade uncertainties, and increasing operational expenses, which impact productivity and profitability [3][11] - Companies are managing higher selling, general and administrative expenses due to performance-related compensation and technology investments [12] Market Performance - The Zacks Agriculture – Operations industry has underperformed the broader Zacks Consumer Staples sector and the S&P 500, with a collective decline of 12.2% over the past year [16] - The industry is currently trading at a forward P/E ratio of 13.34X, compared to the S&P 500's 20.05X and the sector's 17.18X [17]

Core Insights - The article discusses market inefficiencies in fixed-income listed securities, highlighting a specific arbitrage opportunity in exchange-traded traditional preferred stocks [2]. Group 1: Investment Strategies - The company focuses on closed-end funds, monitoring them for directional and arbitrage opportunities due to market price deviations [1]. - Features of the investment service include frequent picks for mispriced preferred stocks and baby bonds, weekly reviews of over 1200 equities, IPO previews, hedging strategies, and an actively managed portfolio [2]. Group 2: Analyst Position - The analyst has a beneficial long position in the shares of CTA.PR.B, indicating a vested interest in the performance of this security [2].

Core Viewpoint - Corteva, Inc. is set to release its first quarter 2025 earnings on May 7, 2025, with a live webcast presentation scheduled for May 8, 2025, at 9:00 a.m. Eastern Time [1]. Group 1 - The earnings release will be available via press release and on the company's website [1]. - A slide presentation accompanying the webcast will be posted on the Investor Events and Presentations page [2]. - A replay of the webcast will be accessible until May 8, 2026 [2]. Group 2 - Corteva, Inc. is a global pure-play agriculture company focused on delivering innovative solutions to address significant agricultural challenges [3]. - The company utilizes a unique distribution strategy and offers a balanced mix of seed, crop protection, and digital products and services [3]. - Corteva aims to maximize productivity for farmers while collaborating with stakeholders in the food system to ensure sustainable progress [3].